Published in Br J Obstet Gynaecol on April 01, 1981
PSG9 Stimulates Increase in FoxP3+ Regulatory T-Cells through the TGF-β1 Pathway. PLoS One (2016) 1.39
Antenatal assessment of the fetus. Can Fam Physician (1986) 0.75
Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. BMJ (1992) 9.08
Maternal serum screening for Down's syndrome in early pregnancy. BMJ (1988) 8.65
A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. Am J Hum Genet (1991) 3.07
A deletion in chromosome 22 can cause DiGeorge syndrome. Hum Genet (1981) 3.04
Genes and languages in Europe: an analysis of mitochondrial lineages. Genome Res (1995) 2.93
MR fluoroscopy: technical feasibility. Magn Reson Med (1988) 2.52
Vasopressin analogue DDAVP in diabetes insipidus: clinical and laboratory studies. Br Med J (1973) 2.41
Alpha-fetoprotein: immunochemical purification and chemical properties. Expression in normal state and in malignant and non-malignant liver disease. Transplant Rev (1974) 2.26
Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci U S A (1998) 2.22
alpha-Fetoprotein in cancer and fetal development. Adv Cancer Res (1979) 2.16
Studies of carcino-fetal proteins. 3. Development of a radioimmunoassay for -fetoprotein. Demonstration of -fetoprotein in serum of healthy human adults. Int J Cancer (1971) 1.97
Optimizing the precision in T1 relaxation estimation using limited flip angles. Magn Reson Med (1987) 1.95
Optic atrophy in Leber hereditary optic neuroretinopathy is probably determined by an X-chromosomal gene closely linked to DXS7. Am J Hum Genet (1991) 1.89
Placental lactogen levels as a screening test for fetal distress and neonatal asphyxia. Lancet (1972) 1.85
Congenital nephrotic syndrome: prenatal diagnosis and genetic counselling by estimation of aminotic-fluid and maternal serum alpha-fetoprotein. Lancet (1976) 1.82
Convenient and quantitative determination of the frequency of a mutant allele using solid-phase minisequencing: application to aspartylglucosaminuria in Finland. Genomics (1992) 1.81
Risk of minor and major fetal malformations in diabetics with high haemoglobin A1c values in early pregnancy. Br Med J (Clin Res Ed) (1984) 1.77
A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases. Nat Genet (1999) 1.76
Developmental changes in carbohydrate moiety of human alpha-fetoprotein. Int J Cancer (1978) 1.72
Microcomputers in antenatal care: a feasibility study on the booking interview. Br Med J (Clin Res Ed) (1981) 1.70
Levels of alpha-fetoprotein in maternal blood as a screening test for fetal neural-tube defect. Lancet (1975) 1.67
Increased alpha fetoprotein in amniotic fluid associated with a congenital esophageal atresia of the fetus. Obstet Gynecol (1973) 1.65
Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene. Nat Genet (1999) 1.65
Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest (1996) 1.64
The cytogenetic effects of mycoplasma in human leukocyte cultures. J Cell Physiol (1967) 1.62
Chromosome damage associated with the measles virus in vitro. Hereditas (1965) 1.60
Changes in gene expression during progression of ovarian carcinoma. Cancer Genet Cytogenet (2001) 1.55
Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer (1986) 1.55
A rapid radioimmunoassay for human chorionic somatomammotrophin. J Obstet Gynaecol Br Commonw (1971) 1.54
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses. Br J Clin Pharmacol (1998) 1.53
Molecular cloning and expression of the human delta7-sterol reductase. Proc Natl Acad Sci U S A (1998) 1.49
Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease. Prenat Diagn (1996) 1.46
The genetic relationship between the Finns and the Finnish Saami (Lapps): analysis of nuclear DNA and mtDNA. Am J Hum Genet (1996) 1.46
Portfolios as a learning tool in obstetrics and gynaecology undergraduate training. Med Educ (2001) 1.45
The development of a radioimmunoassay for oxytocin: the extraction of oxytocin from urine and determination of the excretion rate for exogenous and endogenous oxytocin in human urine. J Endocrinol (1972) 1.43
Early amniocentesis: alphafetoprotein levels in amniotic fluid, extraembryonic coelomic fluid and maternal serum between 8 and 13 weeks. Br J Obstet Gynaecol (1991) 1.42
Lack of evidence for a circadian rhythm of IGFBP-1 in the mother and fetus during labour. Br J Obstet Gynaecol (1995) 1.41
"Salla disease": a new lysosomal storage disorder. Arch Neurol (1979) 1.40
Crown-rump length in aneuploid fetuses: implications for first-trimester biochemical screening for aneuploidies. Prenat Diagn (1995) 1.39
Absence of IgA and growth hormone deficiency associated with short arm deletion of chromosome 18. Arch Dis Child (1973) 1.38
Radioimmunoassay of placental protein 12: levels in amniotic fluid, cord blood, and serum of healthy adults, pregnant women, and patients with trophoblastic disease. Am J Obstet Gynecol (1982) 1.38
Comparison of amniotic-fluid and maternal serum alpha-fetoprotein levels in the early antenatal diagnosis of spina bifida and anencephaly. Lancet (1974) 1.37
Serum alpha-fetoprotein: diagnostic significance in liver disease. Br Med J (1974) 1.37
Complete amino acid sequence of human placental protein 14: a progesterone-regulated uterine protein homologous to beta-lactoglobulins. Proc Natl Acad Sci U S A (1988) 1.36
Simplified method for measuring sex-hormone binding globulin. Clin Chem (1981) 1.35
The development of a radioimmunoassay for oxytocin: the extraction of oxytocin from plasma, and its measurement during parturition in human and goat blood. J Endocrinol (1970) 1.35
Endometrial stromal cells regulate epithelial cell growth in vitro: a new co-culture model. Hum Reprod (2001) 1.34
Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease. EMBO J (1991) 1.33
Specific and sensitive determination of pregnancy-specific beta 1-glycoprotein by radioimmunoassay. A new pregnancy test. Lancet (1977) 1.31
A rapid semi-automated method for the measurement of human chorionic somatomammotrophin. The normal range in the third trimester and its relation to fetal weight. J Obstet Gynaecol Br Commonw (1971) 1.30
Primary structure of human insulin-like growth factor-binding protein/placental protein 12 and tissue-specific expression of its mRNA. FEBS Lett (1988) 1.29
The development of a radioimmunoassay and a plasma extraction method for vasopressin. J Endocrinol (1970) 1.28
Prediction of fetal outcome in threatened abortion by maternal serum placental lactogen and alpha fetoprotein. Am J Obstet Gynecol (1975) 1.27
Excretion of a tumor-associated trypsin inhibitor (TATI) in urine of patients with gynecological malignancy. Int J Cancer (1983) 1.27
Placental protein 12 is a decidual protein that binds somatomedin and has an identical N-terminal amino acid sequence with somatomedin-binding protein from human amniotic fluid. Endocrinology (1986) 1.26
The spectrum of mitochondrial DNA mutations in families with Leber hereditary optic neuroretinopathy. Hum Genet (1993) 1.25
Placental lactogen levels as guide to outcome of threatened abortion. Br Med J (1972) 1.24
Akt activation by estrogen in estrogen receptor-negative breast cancer cells. Cancer Res (2001) 1.23
Attitudes toward genetic testing among the general population and relatives of patients with a severe genetic disease: a survey from Finland. Am J Hum Genet (1995) 1.23
Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab (1988) 1.22
Distribution of placental protein 14 in tissues and body fluids during pregnancy. Br J Obstet Gynaecol (1985) 1.22
-Foetoprotein in normal human serum. Nature (1972) 1.21
Strengths and weaknesses of direct patient interviewing by a microcomputer system in specialist gynaecological practice. Eur J Obstet Gynecol Reprod Biol (1984) 1.20
Circulating levels and tissue localization of placental protein five (PP5) in pregnancy and trophoblastic disease: absence of PP5 expression in the malignant trophoblast. Int J Cancer (1979) 1.20
The spectrum of SLC17A5-gene mutations resulting in free sialic acid-storage diseases indicates some genotype-phenotype correlation. Am J Hum Genet (2000) 1.19
Analysis of mitochondrial ND4 gene DNA sequence in Finnish families with Leber hereditary optic neuroretinopathy. Genomics (1990) 1.19
The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines. Br J Cancer (1996) 1.19
Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease and related neuropathies. Hum Mutat (1998) 1.18
Normal and increased alpha-fetoprotein in neoplastic and non-neoplastic liver disease. Lancet (1972) 1.18
The development of on-line history-taking systems in antenatal care. Methods Inf Med (1983) 1.18
Brefeldin A causes a defect in secretion in Saccharomyces cerevisiae. J Biol Chem (1993) 1.17
Concentrations of pregnancy-specific beta 1-glycoprotein in maternal blood in normal pregnancy and in intrauterine growth retardation. Lancet (1977) 1.17
Suppression by human placental protein 14 of natural killer cell activity. Am J Reprod Immunol (1991) 1.16
Immunochemical demonstration of an ovarian cancer-associated urinary peptide. Int J Cancer (1982) 1.16
Partial trisomy 21. Clin Genet (1973) 1.15
mtDNA haplotype analysis in Finnish families with leber hereditary optic neuroretinopathy. Eur J Hum Genet (1998) 1.14
Spectrum of mutations in aspartylglucosaminuria. Proc Natl Acad Sci U S A (1991) 1.14
Salla disease: a new lysosomal storage disorder with disturbed sialic acid metabolism. Neurology (1983) 1.13
Prenatal diagnosis of congenital nephrosis in 23 high-risk families. Am J Dis Child (1978) 1.13
Audit of compliance with antenatal protocols. BMJ (1992) 1.13
Alpha-fetoprotein in normal and pregnancy sera. Lancet (1972) 1.13
Reevaluation of the linkage of an optic atrophy susceptibility gene to X-chromosomal markers in Finnish families with Leber hereditary optic neuroretinopathy (LHON) Am J Hum Genet (1993) 1.12
Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range. Br Med J (Clin Res Ed) (1984) 1.10
Norrie disease caused by a gene deletion allowing carrier detection and prenatal diagnosis. Clin Genet (1985) 1.10
Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin? Clin Endocrinol (Oxf) (1988) 1.10
Epidemiology of hereditary neuropathy with liability to pressure palsies (HNPP) in south western Finland. Neuromuscul Disord (1997) 1.09
Dipstick method for human chorionic gonadotropin suitable for emergency use on whole blood and other fluids. Lancet (1985) 1.09
Frequency of implantation and early pregnancy loss in natural cycles. Baillieres Clin Obstet Gynaecol (1991) 1.09
alpha-Fetoprotein levels in pregnancies complicated by gastrointestinal abnormalities of the fetus. Br J Obstet Gynaecol (1977) 1.09
In vitro secretion of human chorionic gonadotrophin by bladder tumour cells. Br J Cancer (1987) 1.08
[Radioimmunoassay of alpha-fetoprotein in primary and secondary cancer of the liver]. J Natl Cancer Inst (1972) 1.08
Alpha-fetoprotein in Rh-immunized pregnancies. Obstet Gynecol (1973) 1.07
Release of oxytocin and vasopressin by the human foetus during labour. Nature (1971) 1.07
Detection of trophoblastic tumour activity by pregnancy-specific beta-1-glycoprotein. Int J Cancer (1978) 1.07
Oxytocin release by infused prostaglandin. Br Med J (1972) 1.06
Use of a rapid hCG-beta-subunit radioimmunoassay in acute gynaecological emergencies. Lancet (1980) 1.05